The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Milbemycin Oxime API Market Research Report 2025
Synopsis
Milbemycin is a new type of semi-synthetic macrolide anthelmintic. It is an oxime derivative of Milbemycin A3 and A4. The molecular weight of A3 oxime is 541.7, and the molecular weight of A4 oxime is 555.7. In terms of application, milbexime can be used alone or in combination with nitenpyram, lufenuron, spinosad, praziquantel, etc. to form a compound preparation, which can effectively prevent and control heartworms, hookworms, roundworms, whipworms, roundworms and other internal parasites, as well as hair follicles, scabies, lice, fleas and other external parasites. Milbexime acts as an agonist of the GABA (gamma-aminobutyric acid) neurotransmitter in nerve cells and also binds to glutamate-gated Cl– channels in invertebrate nerve and muscle cells. In both cases, it blocks the parasite's nerve signaling, eventually paralyzing the parasite, causing the muscles to lose their ability to contract, stop feeding, and cause the parasite to die.
The global Milbemycin Oxime API market was valued at US$ 183.7 million in 2023 and is anticipated to reach US$ 304 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
Global 3 largest manufacturers of Milbemycin Oxime API are Livzon Pharmaceutical Group Inc, Zhejiang Hisun Pharmaceutical Co., Ltd and Hubei Honch Pharmaceutical Co.,Ltd, which make up over 40%. Among them, Livzon Pharmaceutical Group Inc is the leader with about 22% market share. North America is the largest market, with a share about 48%, followed by Europe and China, with the share about 46% and 2%. In terms of product type, Purity Greater than 98% occupy the largest share of the total market, about 85%. And in terms of product Application, the largest application is Dog, followed by Cat.
This report aims to provide a comprehensive presentation of the global market for Milbemycin Oxime API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Milbemycin Oxime API.
Report Scope
The Milbemycin Oxime API market size, estimations, and forecasts are provided in terms of output/shipments (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Milbemycin Oxime API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Milbemycin Oxime API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Livzon Pharmaceutical Group Inc
Zhejiang Hisun Pharmaceutical Co., Ltd
Hubei Honch Pharmaceutical Co.,Ltd
JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD
Segment by Type
98% Purity
Purity Greater than 98%
Segment by Application
Dog
Cat
Other
Production by Region
China
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Milbemycin Oxime API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Milbemycin Oxime API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Milbemycin Oxime API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Milbemycin is a new type of semi-synthetic macrolide anthelmintic. It is an oxime derivative of Milbemycin A3 and A4. The molecular weight of A3 oxime is 541.7, and the molecular weight of A4 oxime is 555.7. In terms of application, milbexime can be used alone or in combination with nitenpyram, lufenuron, spinosad, praziquantel, etc. to form a compound preparation, which can effectively prevent and control heartworms, hookworms, roundworms, whipworms, roundworms and other internal parasites, as well as hair follicles, scabies, lice, fleas and other external parasites. Milbexime acts as an agonist of the GABA (gamma-aminobutyric acid) neurotransmitter in nerve cells and also binds to glutamate-gated Cl– channels in invertebrate nerve and muscle cells. In both cases, it blocks the parasite's nerve signaling, eventually paralyzing the parasite, causing the muscles to lose their ability to contract, stop feeding, and cause the parasite to die.
The global Milbemycin Oxime API market was valued at US$ 183.7 million in 2023 and is anticipated to reach US$ 304 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
Global 3 largest manufacturers of Milbemycin Oxime API are Livzon Pharmaceutical Group Inc, Zhejiang Hisun Pharmaceutical Co., Ltd and Hubei Honch Pharmaceutical Co.,Ltd, which make up over 40%. Among them, Livzon Pharmaceutical Group Inc is the leader with about 22% market share. North America is the largest market, with a share about 48%, followed by Europe and China, with the share about 46% and 2%. In terms of product type, Purity Greater than 98% occupy the largest share of the total market, about 85%. And in terms of product Application, the largest application is Dog, followed by Cat.
This report aims to provide a comprehensive presentation of the global market for Milbemycin Oxime API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Milbemycin Oxime API.
Report Scope
The Milbemycin Oxime API market size, estimations, and forecasts are provided in terms of output/shipments (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Milbemycin Oxime API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Milbemycin Oxime API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Livzon Pharmaceutical Group Inc
Zhejiang Hisun Pharmaceutical Co., Ltd
Hubei Honch Pharmaceutical Co.,Ltd
JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD
Segment by Type
98% Purity
Purity Greater than 98%
Segment by Application
Dog
Cat
Other
Production by Region
China
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Milbemycin Oxime API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Milbemycin Oxime API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Milbemycin Oxime API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Milbemycin Oxime API Market Overview
1.1 Product Definition
1.2 Milbemycin Oxime API Segment by Type
1.2.1 Global Milbemycin Oxime API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 98% Purity
1.2.3 Purity Greater than 98%
1.3 Milbemycin Oxime API Segment by Application
1.3.1 Global Milbemycin Oxime API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Dog
1.3.3 Cat
1.3.4 Other
1.4 Global Market Growth Prospects
1.4.1 Global Milbemycin Oxime API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Milbemycin Oxime API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Milbemycin Oxime API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Milbemycin Oxime API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Milbemycin Oxime API Production Market Share by Manufacturers (2019-2024)
2.2 Global Milbemycin Oxime API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Milbemycin Oxime API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Milbemycin Oxime API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Milbemycin Oxime API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Milbemycin Oxime API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Milbemycin Oxime API, Product Offered and Application
2.8 Global Key Manufacturers of Milbemycin Oxime API, Date of Enter into This Industry
2.9 Milbemycin Oxime API Market Competitive Situation and Trends
2.9.1 Milbemycin Oxime API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Milbemycin Oxime API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Milbemycin Oxime API Production by Region
3.1 Global Milbemycin Oxime API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Milbemycin Oxime API Production Value by Region (2019-2030)
3.2.1 Global Milbemycin Oxime API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Milbemycin Oxime API by Region (2025-2030)
3.3 Global Milbemycin Oxime API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Milbemycin Oxime API Production by Region (2019-2030)
3.4.1 Global Milbemycin Oxime API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Milbemycin Oxime API by Region (2025-2030)
3.5 Global Milbemycin Oxime API Market Price Analysis by Region (2019-2024)
3.6 Global Milbemycin Oxime API Production and Value, Year-over-Year Growth
3.6.1 China Milbemycin Oxime API Production Value Estimates and Forecasts (2019-2030)
4 Milbemycin Oxime API Consumption by Region
4.1 Global Milbemycin Oxime API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Milbemycin Oxime API Consumption by Region (2019-2030)
4.2.1 Global Milbemycin Oxime API Consumption by Region (2019-2024)
4.2.2 Global Milbemycin Oxime API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Milbemycin Oxime API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Milbemycin Oxime API Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Milbemycin Oxime API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Milbemycin Oxime API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Milbemycin Oxime API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Milbemycin Oxime API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Milbemycin Oxime API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Milbemycin Oxime API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Milbemycin Oxime API Production by Type (2019-2030)
5.1.1 Global Milbemycin Oxime API Production by Type (2019-2024)
5.1.2 Global Milbemycin Oxime API Production by Type (2025-2030)
5.1.3 Global Milbemycin Oxime API Production Market Share by Type (2019-2030)
5.2 Global Milbemycin Oxime API Production Value by Type (2019-2030)
5.2.1 Global Milbemycin Oxime API Production Value by Type (2019-2024)
5.2.2 Global Milbemycin Oxime API Production Value by Type (2025-2030)
5.2.3 Global Milbemycin Oxime API Production Value Market Share by Type (2019-2030)
5.3 Global Milbemycin Oxime API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Milbemycin Oxime API Production by Application (2019-2030)
6.1.1 Global Milbemycin Oxime API Production by Application (2019-2024)
6.1.2 Global Milbemycin Oxime API Production by Application (2025-2030)
6.1.3 Global Milbemycin Oxime API Production Market Share by Application (2019-2030)
6.2 Global Milbemycin Oxime API Production Value by Application (2019-2030)
6.2.1 Global Milbemycin Oxime API Production Value by Application (2019-2024)
6.2.2 Global Milbemycin Oxime API Production Value by Application (2025-2030)
6.2.3 Global Milbemycin Oxime API Production Value Market Share by Application (2019-2030)
6.3 Global Milbemycin Oxime API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Livzon Pharmaceutical Group Inc
7.1.1 Livzon Pharmaceutical Group Inc Milbemycin Oxime API Corporation Information
7.1.2 Livzon Pharmaceutical Group Inc Milbemycin Oxime API Product Portfolio
7.1.3 Livzon Pharmaceutical Group Inc Milbemycin Oxime API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Livzon Pharmaceutical Group Inc Main Business and Markets Served
7.1.5 Livzon Pharmaceutical Group Inc Recent Developments/Updates
7.2 Zhejiang Hisun Pharmaceutical Co., Ltd
7.2.1 Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Corporation Information
7.2.2 Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Product Portfolio
7.2.3 Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Zhejiang Hisun Pharmaceutical Co., Ltd Main Business and Markets Served
7.2.5 Zhejiang Hisun Pharmaceutical Co., Ltd Recent Developments/Updates
7.3 Hubei Honch Pharmaceutical Co.,Ltd
7.3.1 Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Corporation Information
7.3.2 Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Product Portfolio
7.3.3 Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Hubei Honch Pharmaceutical Co.,Ltd Main Business and Markets Served
7.3.5 Hubei Honch Pharmaceutical Co.,Ltd Recent Developments/Updates
7.4 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD
7.4.1 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Corporation Information
7.4.2 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Product Portfolio
7.4.3 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Main Business and Markets Served
7.4.5 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Milbemycin Oxime API Industry Chain Analysis
8.2 Milbemycin Oxime API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Milbemycin Oxime API Production Mode & Process
8.4 Milbemycin Oxime API Sales and Marketing
8.4.1 Milbemycin Oxime API Sales Channels
8.4.2 Milbemycin Oxime API Distributors
8.5 Milbemycin Oxime API Customers
9 Milbemycin Oxime API Market Dynamics
9.1 Milbemycin Oxime API Industry Trends
9.2 Milbemycin Oxime API Market Drivers
9.3 Milbemycin Oxime API Market Challenges
9.4 Milbemycin Oxime API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
